4.27

1.39% -0.06

Mimedx Group Inc (MDXG)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Mimedx Group Inc stock is traded at $4.27, with a volume of 846.66K. It is down -1.39% in the last 24 hours and up +1.67% over the past month. MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Previous Close:

$4.33

Open:

$4.36

24h Volume:

846.66K

Relative Volume:

0.63

Market Cap:

$622.40M

Revenue:

$389.42M

Net Income/Loss:

$30.70M

P/E Ratio:

20.90

EPS:

0.2043

Net Cash Flow:

$67.23M

1W Performance:

+1.91%

1M Performance:

+1.67%

6M Performance:

-20.19%

1Y Performance:

-41.59%

1-Day Range:

$4.24

$4.39

1-Week Range:

$4.20

$4.50

52-Week Range:

$3.025

$7.97

Mimedx Group Inc Stock (MDXG) Company Profile

Name

Mimedx Group Inc

Sector

Healthcare (1033)

Industry

Biotechnology (582)

Phone

(770) 651-9100

Address

1775 W OAK COMMONS COURT, NE, MARIETTA

Employee

808

Twitter

Next Earnings Date

2026-07-29

Latest SEC Filings

MDXG's Discussions on Twitter

Compare MDXG vs PSNYW, GOODO, SHMD, DWLD, QQQE

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MDXG	6.49	0	0	0	0	0.00
PSNYW Polestar Automotive Holding Uk	2.7213	394.14M	2.07B	-1.42B	-1.37B	-0.6765
GOODO Gladstone Commercial Corporation	21.21	372.90M	0	0	0	0.00
SHMD Schmid Group N V	4.85	315.90M	52.15M	-21.46M	0	-0.4675
DWLD Davis Select Worldwide ETF	47.80	0	0	0	0	0.00
QQQE Direxion NASDAQ-100 Equal Weigh	122.04	0	0	0	0	0.00

Mimedx Group Inc Stock (MDXG) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-23-26	Initiated	Citizens	Mkt Outperform
Jul-02-24	Initiated	Cantor Fitzgerald	Overweight
Mar-07-24	Initiated	Lake Street	Buy
Oct-27-23	Initiated	Craig Hallum	Buy
Oct-13-22	Initiated	Mizuho	Buy
Jul-26-21	Initiated	Northland Capital	Outperform
Mar-19-21	Initiated	H.C. Wainwright	Buy

View All

Mimedx Group Inc Stock (MDXG) Latest News

Aug 20, 2026

Sanara MedTech (SMTI) agrees to MiMedx takeover, targeting year-end close - Stock Titan

Aug 20, 2026

Aug 18, 2026

MiMedx (MDXG) Earnings Metrics: The Bottom-Line Figure Trails Its Comparison at the Close; Immediate Response: Shares Move 3.58% Up on the DayEnergy Earnings Report - vinanet.vn

Aug 18, 2026

Aug 16, 2026

MDXG Q2 2026 Earnings: Wider-than-Expected Loss as EPS Misses Estimates by 106%Post-Announcement Reaction - Vinanet

Aug 16, 2026

Aug 11, 2026

Tranche Update on MiMedx Group, Inc.'s Equity Buyback Plan announced on February 25, 2026. - marketscreener.com

Aug 11, 2026

MiMedx Group (SMTI partner) clarifies Sanara merger fees and $33 cash-plus-stock deal - Stock Titan

Aug 11, 2026

Sanara MedTech Corrects Termination Fees in Merger Deal with MiMedx - Kalkine Media

Aug 11, 2026

Sanara MedTech (SMTI) sets $33 cash plus MiMedx stock merger terms and corrects fees - Stock Titan

Aug 11, 2026

Sanara MedTech (SMTI) sets $33 cash plus MiMedx stock per share in merger - Stock Titan

Aug 11, 2026